在预测左心室逆向改造后干预严重的大动脉 regurgitation 严重的大动脉排泄后的 Généreux 阶段分类
Annalisa Pasquini1, Andrea Pica1, Monica Filice1
1Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo Agostino Gemelli 8 00168, Rome, Italy.
International journal of cardiology
|August 14, 2025
概括
杰内卢斯分期分类预测左心室逆向重塑 (LVRR) 在患有大动脉吐 (AR) 的患者. 在Généreux第一阶段的早期治疗提供了更高的LVRR的机会在门置换后.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 严重的大动脉反 (AR) 导致左心室 (LV) 功能障碍逐渐恶化.
- 大动脉置换 (SAVR或TAVI) 可以逆转大动脉功能障碍和重塑.
- 预测左心室逆转型 (LVRR) 对于治疗决策至关重要.
研究的目的:
- 评估Généreux分期分类能够预测LVRR的能力.
- 评估Généreux阶段在AR治疗后对LVRR的影响.
主要方法:
- 对103名纯慢性AR患者的回顾性分析.
- 在手术前,手术后的早期和6个月后续的心声学评估.
- LVRR定义为减少的LV末缩直径和体积.
主要成果:
- 一般阶段≥2显著降低了LVRR的可能性 (77%早期,74%中期).
- 热内卢斯分期是LVRR的独立预后因素.
- 与SAVR相比,TAVI组的LVRR发生速度较慢.
结论:
- 在AR患者中,Généreux分期有效预测LVRR.
- 在Genéreux第一阶段治疗AR最大限度地提高了LVRR的概率.
- 建议在第一阶段进行早期干预,以改善 LV 恢复.
相关概念视频
Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Aortic Regurgitation III: Medical Management
43
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30


